MedKoo Cat#: 462201 | Name: MJ33-OH lithium

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MJ33-OH lithium is a metabolite of MJ33. MJ33 is an active-site-directed, specific, competitive, and reversible phospholipase A2 (PLA2) inhibitor. MJ33 blocks the calcium-independent phospholipase A2 (iPLA2) activity of Prdx6.

Chemical Structure

MJ33-OH lithium
MJ33-OH lithium
CAS#1135306-36-3 (lithium)

Theoretical Analysis

MedKoo Cat#: 462201

Name: MJ33-OH lithium

CAS#: 1135306-36-3 (lithium)

Chemical Formula: C23H45F3LiO6P

Exact Mass: 512.3066

Molecular Weight: 512.52

Elemental Analysis: C, 53.90; H, 8.85; F, 11.12; Li, 1.35; O, 18.73; P, 6.04

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
1135306-36-3 (lithium) 199106-13-3 (free acid) 1135681-65-0 (S-isomer) 1135266-41-9 (S-isomer Lithium)
Synonym
MJ33-OH lithium; MJ33-OH lithium salt; MJ33-OH lithium; MJ33-OH lithium;
IUPAC/Chemical Name
lithium hydroxymethyl (6,6,6-trifluoro-1-(hexadecyloxy)hexan-2-yl) phosphate
InChi Key
SVCTXBDYZHBOAM-UHFFFAOYSA-M
InChi Code
InChI=1S/C23H46F3O6P.Li/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-30-20-22(17-16-18-23(24,25)26)32-33(28,29)31-21-27;/h22,27H,2-21H2,1H3,(H,28,29);/q;+1/p-1
SMILES Code
O=P(OCO)(O)OC(CCCC(F)(F)F)COCCCCCCCCCCCCCCCC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 512.52 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Shanshan Y, Beibei J, Li T, et al. Phospholipase A2 of Peroxiredoxin 6 Plays a Critical Role in Cerebral Ischemia/Reperfusion Inflammatory Injury. Front Cell Neurosci. 2017;11:99. Published 2017 Apr 5. doi:10.3389/fncel.2017.00099 2: Moawad AR, Fernandez MC, Scarlata E, et al. Deficiency of peroxiredoxin 6 or inhibition of its phospholipase A2 activity impair the in vitro sperm fertilizing competence in mice. Sci Rep. 2017;7(1):12994. Published 2017 Oct 11. doi:10.1038/s41598-017-13411-2. 3:Fisher AB, Dodia C, Feinstein SI, Ho YS. Altered lung phospholipid metabolism in mice with targeted deletion of lysosomal-type phospholipase A2. J Lipid Res. 2005;46(6):1248-1256. doi:10.1194/jlr.M400499-JLR200